#National Cancer Institute

Adding the targeted drug to chemo and radiation treatment is safe and increases the chance that most of the tumor will die before surgery.

Women who took this drug in addition to standard chemotherapy lived longer than those who just received standard chemo.

In recent years, deaths from non-small cell lung cancer (NSCLC) have decreased even faster than the decrease in NSCLC incidence.

Fees to park at cancer facilities can cost patients hundreds of dollars.

These survivors are more likely to develop high cholesterol, high blood pressure, diabetes, thyroid disorder and other chronic conditions.

A new study has found that a microRNA may help drive the transition from normal fallopian tube cells to cancer in the ovary.

To find a better FTO-targeting drug, researchers searched a collection of 260,000 chemicals housed by NCI.

The gene-editing tool can alter the DNA of human cells like a precise pair of scissors.

"These studies can help researchers develop new strategies to improve the care of women with the worst outcomes for this cancer.”

A Fred Hutch cancer prevention researcher was awarded a $3.5M NCI grant to run a randomized trial of smartphone health apps.

The molecular biologist was the first to clone HIV, and she helped prove that the virus causes AIDS. She also researched cancer genetics.

Findings showed that being treated for a mental health disorder increased the chance of survival among veterans with lung cancer.

Women who are uninsured or can’t get regular medical care are more likely to miss out on lifesaving screening.

A greater use of telemedicine has emerged as one of the positive changes that could be continued after the pandemic has passed.

NCI awards Fred Hutch $3.5M to create a colorectal cancer risk calculator based on data from multiethnic populations.

“There was a dramatic reduction [in nausea and vomiting] within 24 hours in the people who received olanzapine."